In this study, four North American Adult T-cell leukemia/lymphoma (NA-ATLL) patient-derived cell lines were analyzed, which included two EP300 wildtype (NA1, NA4) and two EP300 mutants (NA2 and NA3). The gene discussed is EP300; the disease is adult T-cell leukemia/lymphoma.